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Abstract 
To evaluate the apoptosis involvement in the
angiogenesis as a self-limiting process in
patients with temporomandibular joint (TMJ)
degenerated disc vessels, we assessed, by
immunohistochemistry, the detection of
TRAIL, its death receptor DR5 and caspase 3.
TRAIL, its death receptor DR5 and caspase 3
expression were studied by immunohisto-
chemistry in 15 TMJ discs displaced without
reduction and in 4 unaffected discs. These
apoptosis molecules were detected in the inti-
ma and media layers of newly formed vessels
affected discs. In conclusion, vessels apoptosis
activation in TMJ disc with ID could be regard-
ed as a self-limiting process that try to leads to
vessel regression; in this way an inhibition of
angiogenic vessels may prove a key strategy in
limiting pathological angiogenesis, by cutting
off blood supply to tumors, or by reducing
harmful inflammation.
Introduction
The formation of new blood vessels is an
essential part of many physiological and patho-
logical processes including embryogenesis,
wound healing, formation of blood supply to
tumors or ischemic tissue and as a driver of
inflammatory diseases.1-3
Adult human temporomandibular joint
(TMJ) disc is devoid of blood vessels, except
for the bilaminar zone.4,5 The absence of a vas-
cular supply and the compact arrangement of
the fibrous component are considered to be the
morphological characteristics that allow the
human TMJ disc to bear the compression
forces of articulation.6 In contrast, a high den-
sity of blood vessels is described in discs
affected by internal derangement (ID) of the
joint.7-9
ID involves an altered anatomical relation-
ship of the disc-condyle complex and it is like-
ly to lead to histopathological changes that cul-
minate in tissue degeneration as occurs in
disc displacement TMJ discs.10-17 Very little lit-
erature data concerning the distribution of the
newly differentiated capillaries in TMJ ID discs
exists. Since blood capillaries increase in
number with the degree of inflammation dur-
ing tissue repair, previous authors have evalu-
ated CD34 immunoreactivity not only in the
walls of blood capillaries within internal
derangement TMJ disc, but also in the posteri-
or loose connective tissue of bilaminar zone.
CD34 is a human cell antigen usually
expressed by hematopoietic bone marrow pro-
genitor cells and it is used as a sensitive mark-
er of vascular endothelium. The previous find-
ings showed that CD34 immunostaining
appear to be correlated with the severity of
TMJ ID.18 It has also been demonstrated that in
inflammatory, degenerative and hypoxial
states and/or mechanical stress, several
cytokines as interleukin 1 β (IL-1β), prosta -
glandin E (PGE), epidermal growth factor β1
(EGFR-β1), and tumor necrosis factor α (TNF-
α) could activate the vascular endothelium
and initiate angiogenesis inducing the expres-
sion of a cytokine called vascular endothelial
growth factor (VEGF).19-22 Some authors
demonstrated that VEGF was also expressed by
chondrocyte-like cells of perforated TMJ discs,
showing a similar distribution with chondro-
modulin-1 (ChM1) glycoprotein, postulating
that the existence of ChM-1 could neutralize
the angiogenic effect of VEGF preventing, in
this way, blood vessel invasion at the
arthropatic site.
In hypertrophic cartilage VEGF seems to be
released by chondrocytes in a paracrine way,
using endothelial cells as a target23 and that it
is essential to correct directional growth and
cartilage invasion by blood vessels. Moreover,
it has been argued that during an inflammato-
ry process, VEGF could contribute, by chemo-
taxis of macrophage and promoting angiogen-
esis, to the activation of cellular pathways that
induce apoptosis in such proliferative regions. 
Apoptosis, or programmed cell death, is an
integral part of development as seen in
embryogenesis, normal tissue turnover, cellu-
lar homeostasis and a variety of diseases
resulting from its dysregulation.24
Apoptosis processes involve a Fas or tumor
necrosis factor (TNF)-α associated extrinsic
pathway and a mitochondrial associated
intrinsic pathway. In particular, tumor necrosis
factor-related apoptosis-inducing ligand (TRAIL)
Apo-2L is a type II membrane protein, which
can be proteolytically cleaved by cysteine pro-
teases to a soluble form,25 as also shown for
TNF- α and CD95 (Apo-1/Fas) ligand. When
TRAIL binds a death receptor, the death induc-
ing signalling complex assembles at the death
receptor domain, resulting in caspase 8 activa-
tion that causes direct cleavage of caspase 3
into active subunits that execute apoptosis.26
Notably, the vessel wall is a rich source of cys-
teine proteases,27 which suggests that
TRAIL/TRAIL-R systems probably play a physio-
logical role in vascular biology.
Hence in this paper, we examined, through
immunohistochemistry, the detection of
TRAIL, its death receptor DR5 and caspase 3 in
TMJ degenerated disc vessels in order to eval-
uate the apoptosis involvement in angiogene-
sis as a self-limiting process. 
Materials and MethodsPatients and tissues
Specimens were 15 displaced TMJ discs
from the archives of the Pontifical Catholic
University of Paraná, Curitiba, Brazil. The
study was approved by the local ethics commit-
tee. The informed consent of each patient was
obtained before disc removal. Discs came from
12 women and 3 men with TMJ ID. All had
anterior disc displacement without reduction
(ADDwoR), as confirmed by clinical history,
physical examination and magnetic resonance
imaging (MRI). Their mean age at the time of
surgery was 37.2 years (±4.4); the mean inter-
val from ID symptom onset to surgery was 7.9
months (±0.6). Unassisted maximum mouth
opening (MMO), determined with a millimeter
ruler as interincisal distance, and a visual ana-
log scale (VAS), to measure pain intensity in
the preceding week, were used to assess dis-
ease severity. The VAS anchor points were 0
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for “no pain” and 100 for “the worst imagina-
ble pain.” These data are reported in Table 1.
The diagnosis that led to surgery was TMJ
ID with pain and functional impairment.
Inclusion criteria were: i) unsuccessful non-
surgical treatment; ii) TMJ tenderness to pal-
pation; and iii) TMJ pain or interference with
mandibular movements. Exclusion criteria
were: i) other TMJ diseases; ii) dentofacial
deformity; ii) major jaw trauma; iv) previous
TMJ surgery; and v) previous TMJ steroid
injections. After removal, all discs were seen to
be macroscopically deformed, none having a
normal biconcave shape. 
Discectomy has come under increasing
attack as the standard therapy for disc dis-
placement, with a number of surgeons now
favoring a conservative approach and other
researchers still believing in its value.28-30 Disc
removal is therefore ethically justified. This
small sample of whole TMJ discs was investi-
gated because they provide exhaustive infor-
mation on the characteristics of tissue degen-
eration.
Four virtually unaffected human TMJ discs
from the collection of the Anatomy Institute of
Catania University, Catania, Italy, were studied
for comparison. These paraffin-embedded
autopsy specimens from one male and three
female subjects (mean age 49.7±4.4 years)
were selected because the donors’ clinical his-
tories were negative for generalized joint dis-
ease or TMJ arthropathy. On dissection the
discs showed no macroscopic signs of degener-
ative or inflammatory joint disease or displace-
ment. They were stained with Harry’s hema-
toxylin and exhibited no detectable pathologi-
cal changes on light microscopy. Immunohistochemistry
For the immunohistochemical staining the
discs were fixed overnight in 10% neutral
buffered formalin (Bio-Optica, Milan, Italy).
After fixation and overnight washing, each
disc was sectioned through its center along a
parasagittal plane, perpendicular to its long
axis. Each tissue block was dehydrated in grad-
ed ethanol, and embedded in paraffin preserv-
ing the longitudinal anatomical orientation.
Specimens were sectioned at a thickness of 5
µm and placed on silanized glass slides (the
anterior band being always on the right side of
the slides). Endogenous peroxidase activity
was quenched by treatment with 3% H2O2 for
10 min. Non-specific binding of antibodies was
blocked by normal horse/goat serum treatment
[diluted 1:20 in phosphate buffered saline
(PBS), 0.1% bovine serum albumin (BSA)].
The sections were irradiated (5 min¥3) in
capped polypropylene slide-holders with citrate
buffer (pH 6), using a microwave oven (750 W)
to unmask antigenic sites. 
A rabbit polyclonal anti-caspase 3 antibody
(Cell Signaling Technology, Inc., Denver, MA,
USA), a rabbit polyclonal anti-TRAIL (Santa
Cruz Biotecnology, Inc., CA, USA) and a rabbit
polyclonal anti-DR5 (Novus Biologicals, Inc.,
Littleton, USA) used respectively at 1:100, 1:20
and 1:20 working dilution (in PBS, 0.1% BSA),
were applied on each section and incubated
overnight at +4°C in a moist chamber.
Immunocomplexes were detected by incuba-
tion with the secondary antibody and then with
streptavidin-peroxidase complexes for 15 mins
each at room temperature (LSAB2/HRP kit,
DAKO, Denmark). After rinsing in 3 changes
of PBS, the immunoreaction was visualized by
incubating sections in a 0.1% 3.3'-diaminoben-
zidine and 0.02% hydrogen peroxide solution
(DAB substrate kit, Vector Lab., Burlingame,
CA, USA) for 4 min. The sections were lightly
counterstained with Mayer’s haematoxylin
(Histolab Products AB, Goteborg, Sweden) and
finally mounted on GVA mount (Zymed
Laboratories Inc., San Francisco, CA, USA). Evaluation of immunohistochemistry
TRAIL, DR5 and caspase 3 stain intensity
and the proportion of immunopositive cells
were examined, blinded by light microscopy
and recorded. Intensity of staining (IS) was
graded on a scale range from 0 to 4, according
to the following semiquantitative assessment:
0=no detectable staining, 1=weak staining,
2=moderate staining, 3=strong staining,
4=very strong staining. The percentage of
TRAIL, DR5 and caspase 3 immunopositive
cells (extent score=ES) was also independent-
ly evaluated and scored as a percentage of the
final number of 200 cells in four categories:
0≤5%; 1=6-30%; 2=31-50%; 3≥50%, and
4≥75%. Counting was performed at X 200 mag-
nification. The final staining score (FSS) was
derived from the sum of the intensity score
added to the extent score. Positive and negative control
This was performed to test the specific reac-
tion of the primary antibody at protein level.
For positive control testing basal cell carci-
noma tissue was exposed to an immunoperox-
idase process. For negative controls, randomly
selected TMJ disc sections were treated with
normal rabbit serum instead of the specific
antibody.
Statistical analysis
Data were analyzed using the Mann-
Whitney U-tests; P<0.05 were considered sig-
nificant. Mean and standard deviation were
calculated for both the FSS and HDS. All data
were analyzed with the SPSS program (SPSS®
release 16.0, Chicago, IL, USA). 
Results
All TMJ patients had been unsuccessfully
treated with other various interventions for at
least 8 months prior to surgery. The control
discs showed preservation of multidirectional
collagen bundles, predominately fibrocyte-like
cell populations with few chondrocytes-like
cells aggregates, and absence of clefts or fray-
ing and vascular vessels. In contrast diseased
disc sections, stained with hematoxylin
showed a different degree of morphologic dam-
age, ranging from an altered collagen bundle
structure to fragmention and the presence of
newly formed vessels. A high immunoexpres-
sion of TRAIL (Figure 1 A, B), its receptor DR5
(Figure 2 A, B) and caspase 3 (Figure 3 A, B)
was demonstrated in the intima and media lay-
ers of newly formed vessels where cells were
strongly positive (IS score=3). The mean FSS
of all samples was 4.60±0.54 (range 3.4-5.8). 
Immunohistochemical reactivity for TRAIL
and caspase-3 was detected in cells cytoplasm,
and the immunoexpression of DR5 was recog-
nized in cell membrane and cytoplasm. 
Discussion
TMJ ID is often accompanied by chronic
inflammatory changes including growth of
small new vessels.31-34 It would seem that these
degenerative changes, as in other joints, are
influenced by the kind (anterior disc displace-
ment with or without reduction) and the
degree of disc displacement. Our study evi-
denced a high immunoexpression of TRAIL, its
receptor DR5 and caspase 3 in the intima and
media layers of newly formed vessels that
reflects an activation of the apoptosis mecha-
nism in these structures. Apoptosis process is
Original paper
Table 1. Clinical characteristics of patients with anterior disc displacement without
reduction.
Patients’ age Unassisted Visual analog scale
mouth opening maximum
MV SD MV SD MV SD
ADDwoR 34.4 4.2 27.4 4.6 83 6
MV, mean value; SD, standard deviation.
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in fact activated by the extrinsic pathway,
through TRAIL which cross-linking DR4 and
DR5 receptors death on the surface of target
cells particularly in microvascular endothelium
as mechanism of defence. 
Some authors have just tried to understand
how the process of formation of new vessels,
including endothelial proliferation, migration
and tube formation, is limited through induc-
tion of endothelial apoptosis, which leads to
vessel regression. However, literature reports
on the pro-angiogenetic or anti-angiogenetic
action of TRAIL, in in vitro studies, showed
contrasting results. Some authors evidenced
the stimulatory effect of TRAIL on cell endothe-
lial proliferation and its inducing activation of
Akt and Erk that leads to endothelial prolifera-
tion, increased cell migration and tube forma-
tion without altering endogenous endothelial
expression of VEGF35,36 while others, on the
contrary, demonstrated that TRAIL was found
to inhibit tube formation, cell numbers and
endogenous VEGF expression.37 Probably the
anti-angiogenic action of TRAIL is induced by
higher doses of this ligand.38 Actually, the
growth of microvessels by VEGF acts through
Akt pathway and can be blocked when Akt is
inhibited by various anti-angiogenic factors
namely angiotensin II and thromboxane A2.39,40
The ability of TRAIL to activate the antiapop-
totic PI3k/Akt pathway in endothelial cells is
also an unexpected finding.41 A possible expla-
nation is that the PI3k/Akt impairs the activa-
tion of the apical caspases by inhibiting the
recruitment of procaspase-8 to the death-
inducing signalling complex.42 Really, as for
others morphological features just observed in
TMJ diseases, only restricted and focal areas of
new vascular profiles have been revealed. 
Thus, our present study sustains the hypoth-
esis that angiogenesis reports in degenerative
disc tissue are maintained localized thanks to
the apoptotic process. In particular, we demon-
strated both an activation of the process
through the receptor pathway and the progres-
sion of cell death through the activation of the
executioner caspase 3 that, in turn, leads to
cytoskeletal proteins degradation and DNA
fragmentation. It is suggested that TRAIL selec-
tively binds death receptor DR5 endothelial
cells in a dose dependent manner and enhance
apoptosis by caspase 8 and caspase 3 pathway.
Our previous study on TMJ disc ID demonstrat-
ed that TRAIL was overexpressed in apoptotic
chondrocyte like cells,43,44 tissue apoptotic cell
death seems to be responsible for disc tissue
degeneration being correlated with the severi-
ty of disc pathologic findings.45-47 For patients
with complete TMJ meniscus dislocation with
internal derangement, some indications that
this tissue is undergoing adaptive changes
include the presence of thickened arterial walls
suggesting a decreased blood flow.48
In conclusion, this study allows to hypothe-
size that angiogenesis is maintained localized
thanks to the apoptotic process in degenera-
tive disc tissues, thus vessel apoptosis activa-
tion in TMJ disc with ID could be regarded as a
self-limiting process that tries to lead to vessel
regression. In this way an inhibition of angio-
genic vessels may prove to be a key strategy in
limiting pathological angiogenesis, by cutting
off the blood supply to tumors or by reducing
harmful inflammation. 
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Figure 1. (A) TRAIL immunostaining in the posterior band of TMJ ID disc (x40); (B)
Immunopositive vascular vessels are indicated with arrows (x80). Bar: 100 mm.
Figure 2. (A) DR5 immunostaining in the posterior band of TMJ ID disc (x40); (B)
Immunopositive vascular vessels are indicated with arrows (x100). Bar: 100 mm.
Figure 3. (A) Caspase 3 immunostaining in the posterior band of TMJ ID disc (x40); (B)
Immunopositive vascular vessels are indicated with arrows (x100). Bar: 100 mm.
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